| Title | Societal Costs of Rheumatoid Arthritis in China: A Hospital-Based Cross-Sectional Study |
| Authors | Xu, Chuanhui Wang, Xiuru Mu, Rong Yang, Li Zhang, Ye Han, Shuling Li, Xiaofeng Wang, Yongfu Wang, Guochun Zhu, Ping Jin, Hongtao Sun, Lin Chen, Haiying Cui, Liufu Zhang, Zhuoli Li, Zhenbin Li, Junfang Zhang, Fengxiao Lin, Jinying Liu, Xiaomin Hu, Shaoxian Yang, Xiuyan Lai, Bei Li, Xingfu Wang, Xiaoyuan Su, Yin Li, Zhanguo |
| Affiliation | Peking Univ, Peoples Hosp, Hlth Sci Ctr, Beijing 100871, Peoples R China. Peking Univ, Shougang Hosp, Beijing 100871, Peoples R China. Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China. Shanxi Med Univ, Affiliated Hosp 2, Taiyuan, Peoples R China. Baotou Med Coll, Affiliated Hosp 1, Baotou, Peoples R China. China Japan Friendship Hosp, Beijing, Peoples R China. Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China. Hebei Med Univ, Affiliated Hosp 2, Shijiazhuang, Peoples R China. Peking Univ, Hosp 3, Beijing 100871, Peoples R China. Hebei Med Univ, Affiliated Hosp 3, Shijiazhuang, Peoples R China. North China Coal Med Univ, Affiliated Kailuan Hosp, Tangshan, Hebei, Peoples R China. Peking Univ, Hosp 1, Beijing 100871, Peoples R China. Bethune Int Peace Hosp PLA, Shijiazhuang, Peoples R China. Handan Cent Hosp, Handan, Peoples R China. Peoples Hosp Hebei Prov, Shijiazhuang, Peoples R China. Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China. China Med Univ, Beijing Shunyi Hosp, Beijing, Peoples R China. Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China. Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China. Beijing Hosp, Beijing, Peoples R China. Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China. Lanzhou Univ, Affiliated Hosp 2, Lanzhou 730000, Peoples R China. Peking Univ, Peoples Hosp, Hlth Sci Ctr, Dept Rheumatol & Immunol, 11 Xizhimen South St, Beijing 100871, Peoples R China. |
| Keywords | ANKYLOSING-SPONDYLITIS ECONOMIC BURDEN MEDICAL COSTS OF-ILLNESS HONG-KONG PREVALENCE DISEASE CARE PREDICTORS MANAGEMENT |
| Issue Date | 2014 |
| Publisher | arthritis care research |
| Citation | ARTHRITIS CARE & RESEARCH.2014,66,(4),523-531. |
| Abstract | ObjectiveTo estimate the annual direct and indirect costs of rheumatoid arthritis (RA) in China and identify the predictors for cost of illness. MethodsA cross-sectional study of cost of illness from the societal perspective was conducted on 829 patients with RA in 21 tertiary care hospitals in China between July 2009 and December 2010. Data on demographics, clinical variables, and components of costs were collected by physician interview. Costs were represented in 2009 US dollars using purchasing power parity estimates. Univariate and multivariate linear regression analyses were performed to identify the predictors for cost of illness. ResultsThe mean SD total cost of RA in China was $3,826 +/- $5,659 per patient-year, given a gross domestic product per capita of $6,798 in China in 2009. Direct costs and indirect costs comprised 90.0% and 10.0% of the total costs, respectively. Drug expense represented approximately half of the total costs, dominated by biologic agents (48.2%) and disease-modifying antirheumatic drugs (23.5%). Additionally, the cost of extracted herbal drugs and traditional Chinese medicine comprised approximate to 17.6% of the drug expense. Higher education level, noninsured status, longer disease duration, more extraarticular manifestations, and higher Health Assessment Questionnaire score independently predicted higher total costs. ConclusionOur results provide the first study of costs of RA in China. This study not only demonstrates the economic burden of RA, but also identifies the predictors that could be interventional factors to reduce the societal costs of RA in China. |
| URI | http://hdl.handle.net/20.500.11897/159237 |
| ISSN | 2151-464X |
| DOI | 10.1002/acr.22160 |
| Indexed | SCI(E) PubMed |
| Appears in Collections: | 人民医院 首钢医院 第三医院 第一医院 |
